TEK2day FINANCE Open Terminal →

Stereotaxis, Inc. (STXS)

ASE · Healthcare · Medical Instruments & Supplies

$1.84 +1.10%

Closing price as of 2026-06-12 · Source: TEK2day Finance

1-Year Price History -15.2% over period
$4$3$3$2$2 2025-062025-092025-122026-032026-06

Key Metrics

Market Cap
$196.0M
P/S (TTM)
6.3x
Exchange
ASE

About Stereotaxis, Inc.

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Quarterly Financials

Metric2025-06-302025-09-302025-12-312026-03-31
Revenue8.8M7.5M8.6M6.3M
Gross Profit4.6M4.1M4.3M3.8M
Operating Income-4.0M-6.6M-5.6M-6.0M
Net Income-3.8M-6.5M-5.5M-5.9M
Diluted EPS$-0.05$-0.07$-0.06$-0.06

Annual Financials

Metric2022-12-312023-12-312024-12-312025-12-31
Revenue28.1M26.8M26.9M32.4M
Gross Profit18.5M14.9M14.6M17.1M
Operating Income-18.8M-21.8M-24.7M-22.1M
Net Income-18.3M-20.7M-24.0M-21.6M
Diluted EPS$-0.26$-0.27$-0.30$-0.25
Want live quotes, estimates, SEC filings, and CEO analytics for STXS?
The free TEK2day terminal runs in your browser — type /STXS to get started.
Open STXS in the Terminal →